What the company does:Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally.
📈 Novanta (NOVT) stock price
$144.65+22.5% over range
Loading…
Aug 28, 25low $99.22 · high $168.75Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 1 analysts
📊 JPI status :Novanta has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
The price target · all analysts combined (1 targets)
Highest target · 1 firm of 1$173+19.6%
Median target · of 1 targets$173+19.6%
Lowest target · 1 firm of 1$173+19.6%
Current price$144.65
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
In short —$1,000 invested in Novanta 10 years ago would be worth $11,912 today, i.e. +28%/yr on average. Best year: 2017 (+138%), worst: 2022 (-23%). Price performance, excluding dividends.
🎯 on NOVT : 100%(1 call matured) · 📊 on Tech : 41.4% · +6.8%(87 calls)
+27.4%
stock +27% · XLK +3%
matured Dec 8, 18
Frequently asked questions
Should I buy Novanta stock?
This isn't buy advice. For Novanta, the analyst consensus is "Buy", with an average price target of $173 (+20% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Novanta). We show the numbers — you decide.
Is it too late to buy Novanta? How high can it go?
The most bullish analyst target on Novanta is $173 (+20% above today's price); the average is $173. That's the upside they see. Check how reliable those analysts have actually been on Novanta on our site before trusting it.
Is Novanta still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 1 analyst have a real record on Novanta, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.